Physician profile
John R Ehteshami
NPI 1457518391
$28,607.08
in general payments reported to CMS, 2019-2025
26 companies · $12K in 2025
The $12K reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $227 · 2021: $517 · 2022: $988 · 2023: $501 · 2024: $2,307 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $2,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,750.00 |
| Food and Beverage | $2,128.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $14,222.26 | 2021-2025 | |
| Smith+Nephew, INC. | $6,609.03 | 2019 | |
| Osiris Therapeutics INC. | $3,761.44 | 2019 | |
| Seaspine Orthopedics Corporation | $715.59 | 2019 | |
| Nuvasive, INC. | $640.03 | 2019-2023 | |
| Orthofix Medical, INC. | $450.66 | 2019-2022 | |
| Stryker Corporation | $388.75 | 2019-2024 | Spinejack |
| Medtronic, INC. | $355.01 | 2022 | |
| Alphatec Spine, INC | $328.33 | 2019-2021 | |
| Zimvie INC. | $272.59 | 2023-2024 | |
| Highridge Medical LLC | $225.01 | 2024-2025 | Mobi-C Plug & Fit US, Vital |
| Globus Medical, INC. | $148.92 | 2025 | Reline |
| Abbott Laboratories | $106.85 | 2021 | |
| Icotec Medical INC. | $104.33 | 2023 | Icotec Blackarmor Spine System |
| Centinel Spine, LLC | $52.71 | 2024 | Prodisc C Vivo |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $51.00 | 2019-2022 | |
| Cerapedics INC. | $46.62 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Baxter Healthcare | $24.39 | 2023 | Floseal |
| Biocomposites INC | $17.11 | 2021 | |
| Medtronic USA, INC. | $16.91 | 2019 | |
| Sk Life Science, INC. | $15.40 | 2021 | |
| Neurelis, INC. | $14.12 | 2020 | |
| Theragen, INC. | $14.00 | 2025 | Actastim-S |
| Boston Scientific Corporation | $13.94 | 2023 | Upsylon |
| Almatica Pharma LLC | $12.08 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ehteshami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.